Alzamend Neuro logo

Alzamend Neuro Share Price (NASDAQ: ALZN)

$2.27

0.01

(0.44%)

Live

Last updated on

Check the interactive Alzamend Neuro Stock chart to analyse performance

Alzamend Neuro Inc Key Stats

Check Alzamend Neuro key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$2.26
Open
$2.32
Market Capitalization
$7.5M
Today's Volume
$74.4K
Revenue TTM
$0.0
EBITDA
$-4.4M
Earnings Per Share (EPS)
$-101.88
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-657.17%

Stock Returns calculator for Alzamend Neuro Stock including INR - Dollar returns

The Alzamend Neuro stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Alzamend Neuro investment value today

Current value as on today

₹9,725

Returns

₹90,275

(-90.27%)

Returns from Alzamend Neuro Stock

₹94,202 (-94.2%)

Dollar Returns*

₹3,927 (+3.93%)

Indian investors sentiment towards Alzamend Neuro Stock

56%

Period: Jul 21, 2025 to Aug 20, 2025. Change in 30 Days versus previous period

Search interest for Alzamend Neuro Stock from India on INDmoney has increased by 56% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Alzamend Neuro Inc

  • Name

    Holdings %

  • BlackRock Inc

    0.01%

Analyst Recommendation on Alzamend Neuro Stock

Rating
Trend

Buy

    75%Buy

    25%Hold

    0%Sell

Based on 8 Wall street analysts offering stock ratings for Alzamend Neuro(by analysts ranked 0 to 5 stars)

Alzamend Neuro Share Price Target

What analysts predicted

Upside of 7829.52%

Target:

$180.00

Current:

$2.27

Alzamend Neuro share price target is $180.00, a slight Upside of 7829.52% compared to current price of $2.27 as per analysts' prediction.

Alzamend Neuro Stock Insights

  • Price Movement

    In the last 1 month, ALZN stock has moved down by -30.7%
  • ALZN vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 64.1% return, outperforming this stock by 158.3%
  • ALZN vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 112.1% return, outperforming this stock by 211.9%

Alzamend Neuro Technicals Summary

Sell

Neutral

Buy

Alzamend Neuro is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Alzamend Neuro Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Alzamend Neuro Inc logo
-29.38%
-75.38%
-94.23%
-99.83%
-99.99%
Regeneron Pharmaceuticals, Inc. logo
5.39%
-15.07%
-50.13%
-3.42%
-0.61%
Beone Medicines Ltd logo
4.61%
26.63%
56.19%
78.75%
30.26%
Vertex Pharmaceuticals Incorporated logo
-16.11%
-17.89%
-18.87%
34.22%
47.47%
Alnylam Pharmaceuticals, Inc. logo
40.82%
82.49%
64.08%
110.21%
247.67%

About Alzamend Neuro Inc

Alzamend Neuro, Inc., a clinical-stage biopharmaceutical company, focuses on developing various products for the treatment of neurodegenerative and psychiatric disorders. Its pipeline includes AL001, which delivers a therapeutic combination of lithium, proline, and salicylate for the treatment of Alzheimer's, bi-polar disorder, post-traumatic stress disorder, major depressive disorder, other neurodegenerative diseases, and psychiatric disorders; and ALZN002, which uses a method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine to restore the ability of a patient's immunological system to combat Alzheimer's disease. Alzamend Neuro, Inc. was incorporated in 2016 and is headquartered in Atlanta, Georgia.
Organization
Alzamend Neuro
Employees
4
CEO
Mr. Stephan Jackman
Industry
Miscellaneous

Key Management of Alzamend Neuro Inc

NameTitle
Mr. Stephan Jackman
CEO & Director
Mr. Milton Charles Ault III
Founder & Vice Chairman
Mr. David J. Katzoff
Chief Financial Officer
Mr. Henry C. W. Nisser Esq.
Executive VP, General Counsel & Director

Important FAQs about investing in ALZN Stock from India :

What is Alzamend Neuro share price today?

Alzamend Neuro share price today is $2.27 as on . Alzamend Neuro share today touched a day high of {{1_rba_end}} and a low of {{1_rba_st}}.

What is the 52 week high and 52 week low for Alzamend Neuro share?

Alzamend Neuro share touched a 52 week high of {{rba_end}} and a 52 week low of {{rba_st}}. Alzamend Neuro stock price today i.e. is trending at $2.27, lower by 95.24% versus the 52 week high.

How to invest in Alzamend Neuro Stock (ALZN) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Alzamend Neuro on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Alzamend Neuro Shares that will get you 0.6608 shares as per Alzamend Neuro share price of $2.27 per share as on August 22, 2025 at 12:41 AM IST.

What is the minimum amount required to buy Alzamend Neuro Stock (ALZN) from India?

Indian investors can start investing in Alzamend Neuro (ALZN) shares with as little as ₹87.2 or $1 (as of August 21, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹872.00 in Alzamend Neuro stock (as per the Rupee-Dollar exchange rate as on August 21, 2025). Based on Alzamend Neuro share’s latest price of $2.27 as on August 22, 2025 at 12:41 AM IST, you will get 4.4053 shares of Alzamend Neuro. Learn more about fractional shares .

What are the returns that Alzamend Neuro has given to Indian investors in the last 5 years?

Alzamend Neuro stock has given -99.99% share price returns and 17.57% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your US Stock Investments?